In line / mixed
Nine-month sales reached CHF8.92B, up 9.1% in local currencies and 5.5% in Swiss francs. EBITDA rose 13.2% to CHF1.70B and margin expanded to 19.1% from 17.8%. Organic growth accelerated across the nine-month period.
[AS-017]Sika AG
9M 2024 sales update: Local-currency growth accelerated and EBITDA margin expanded sharply, validating the MBCC synergy bridge despite a still-mixed construction backdrop.
ResultIn line / mixedGuidanceMaintainedEnvironmentmixed
Investment snapshot
What happened and why it mattered
Maintained
Sika reiterated 6–9% local-currency sales growth and over-proportional EBITDA growth for 2024.
[AS-017]No clear inflection
The guide implied continued Q4 growth with EBITDA rising faster than sales, supported by MBCC synergies.
[AS-017]-0.4%
The near-flat reaction reflected sound execution but limited incremental surprise relative to an already improving margin narrative.
[MKT-001]Results versus expectations
The print and the three most important read-throughs
Nine-month sales reached CHF8.92B, up 9.1% in local currencies and 5.5% in Swiss francs. EBITDA rose 13.2% to CHF1.70B and margin expanded to 19.1% from 17.8%. Organic growth accelerated across the nine-month period.
- 1
Nine-month sales reached CHF8.92B, up 9.1% in local currencies and 5.5% in Swiss francs.
- 2
EBITDA rose 13.2% to CHF1.70B and margin expanded to 19.1% from 17.8%.
- 3
Organic growth accelerated across the nine-month period.
Guidance bridge
GuidanceMaintainedLatest outlook and KPI implications
Sika reiterated 6–9% local-currency sales growth and over-proportional EBITDA growth for 2024.
| Metric | Prior | Latest | Consensus | Delta | Status | Reason / implication |
|---|---|---|---|---|---|---|
| 2024 sales growth in local currencies | 6–9% | 6–9% | Not consistently available | No change | Reiterated | Pricing, M&A and organic growthQ4 must remain positive |
| 2024 EBITDA growth | Over-proportional to sales | Over-proportional to sales | Not consistently available | No change | Reiterated | MBCC synergiesMargin expansion continues |
| 2024 EBITDA margin | No formal numerical range | 19.1% at 9M | Not consistently available | Ahead of prior year | Directional | Reported nine-month performanceFY margin near 19% implied |
| MBCC synergies | Existing integration plan | On track | Not consistently available | No change | Reiterated | Procurement and footprintSupports Q4 and 2025 |
| Currency translation | Negative | Continued headwind | Not consistently available | No change | Directional | Swiss francReported growth below LC growth |
Management signal — paraphrased
The environment supported better organic exit rates and margin resilience, with China and autos limiting the group growth rate.
Implied cadence
The guide implied continued Q4 growth with EBITDA rising faster than sales, supported by MBCC synergies.
Stock reaction
Why the shares moved
The near-flat reaction reflected sound execution but limited incremental surprise relative to an already improving margin narrative.
- Local-currency growth
- 130bp margin expansion
- FY guide held
Did the reaction persist?
[MKT-001]The stock was roughly flat on day one and about 3% lower after five sessions.
Adjusted-close reaction
Independently calculated adjusted-close returns
| Window | Stock | vs benchmark | vs peers |
|---|---|---|---|
| 1D | -0.4% | -0.5% | -0.8% |
| 2D | +1.3% | +0.8% | -1.6% |
| 5D | -3.0% | +0.1% | -5.3% |
Market environment delta
EnvironmentmixedWhat management said about the operating backdrop
Organic growth and material margins improved sequentially, but China construction and European automotive demand remained weak.
- Volumes / order activityImproving
"Continued steady improvement in organic growth from 0.2% in Q1 to 1.7% in Q3"
OutlookMomentum into Q4/FY25KPI implicationOrganic exit rate the key debateQuantified datapoint · High confidence · AS-ME-017 - Regional / end-marketMixed
EMEA +9% LC (ME/Africa/E.Europe strong, Germany still negative); Americas +12.2% LC (US infra/reshoring, Q3 organic 4.3%); Asia/Pacific +4.7% LC, organic −0.5% on China; autos declining on European new-vehicle downturn
OutlookUS and ME/Africa engines; China and autos drags persistKPI implicationRegional organic divergence defines the printQuantified datapoint · High confidence · AS-ME-017
- Channel / inventoryMixed
China distribution grew moderately despite sluggish residential; project business declined; POS expansion continued
OutlookDistribution roll-out extends to other marketsKPI implicationChina ~11–12% of sales; direct sales double-digit declineStatement · Medium confidence · AS-ME-017 - Supply availability / footprintImproving
New Liaoning (China) mortar/tile-adhesive plant plus Indonesia Bekasi capacity doubling supporting distribution demand
OutlookFootprint expansion to capture SE Asia/China distributionKPI implicationCapex supports future organic captureStatement · Medium confidence · AS-ME-017 - Input costs / capacityImproving
"Generally declining at flattening material costs"; procurement initiatives and MBCC synergies drove Q3 material margin slightly above prior year
OutlookFlattening costs; synergy support to marginKPI implicationMaterial margin 54.7% (9M), +160bps YoYQuantified datapoint · High confidence · AS-ME-017
- CompetitionImproving (share) / overhang (probe)
Reiterated share gains; CEO expects the 6-month outperformance spread vs peers "to enlarge"; ongoing price-fixing investigation "hasn't reached an advanced preliminary stage"
OutlookWider peer outperformance; probe may "take years"KPI implicationSupports organic premium; legal-sentiment overhangStatement · Medium confidence · AS-ME-017 - PricingStable / mixed
"Adaptive pricing" the priority; relatively stable now but logistics/commodity spikes possible; refrains from firm pricing guidance
OutlookManage price-cost dynamically by product/geographyKPI implicationUnderpins material margin at 54.7%Statement · Medium confidence · AS-ME-017
Evidence and confidence
Source map
Consensus snapshots are reconstructed from contemporaneous broker notes; the flattened AlphaSense export does not preserve stable document URLs.
AlphaSense synthesis
Open source ↗Official company source
Open source ↗AlphaSense market-environment synthesis
Open source ↗